Mycosis fungoides (MF) is the most common type of cutaneous T-cell lymphoma. It is characterized by malignant T-cell lymphocytes in the skin. It presents as patch, plaque, or tumor stage and is ...

The diagnostic guidelines used to identify two distinct subsets of T-cell lymphomas—the leukemic variant Sézary syndrome and ...

The most common type of CTCL is mycosis fungoides (MF). Mycosis fungoides was so named by a French dermatologist in the 1800s due to the mushroom like tumors that developed on the skin of a ...

Considering taking supplements to treat mycosis fungoides? Below is a list of common natural remedies used to treat or reduce the symptoms of mycosis fungoides. Follow the links to read common ...

mycosis fungoides, relapsed or refractory non-Hodgkin's lymphoma as part of a metronomic combination regimen, rheumatoid arthritis and severe psoriasis; and for the treatment of pediatric patients ...

Romidepsin (Istodax) is an antineoplastic agent. It is formulated as lyophilized powder for solution for intravenous administration. Istodax is approved for the treatment of cutaneous T-cell lymphoma ...

Nivolumab is under clinical development by Bristol-Myers Squibb and currently in Phase II for Metastatic Uveal Melanoma.

mycosis fungoides, relapsed or refractory non-Hodgkin's lymphoma as part of a metronomic combination regimen, rheumatoid arthritis and severe psoriasis Treatment of pediatric patients with ...

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today reported its consolidated financial results for the six months ended June 30, 2024. The consolidated financial ...

Haematological diseases are pathological conditions primarily affecting the blood or blood-producing organs. This group of disorders includes, but is not limited to, various types of anaemia ...

STRATA’s mission, designed to offer support for conditions such as mycosis fungoides, lichen planus, alopecia areata, and cutaneous T-Cell lymphoma (CTCL), initially zeroes in on vitiligo and ...

Northvale, New Jersey-- (Newsfile Corp. - August 27, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products, ...